GenomeDx Biosciences' Series D - II Round

GenomeDx Biosciences raised a round of funding on September 25, 2018.

GenomeDx Biosciences develops and commercializes genomic tests for prostate, bladder and other urologic cancers that have a direct impact on treatment decision-making, improve patient outcomes and ult…

Articles about GenomeDx Biosciences' Series D - II Round: